| Current Price | $1.27 | Mkt Cap | $144.4M |
|---|---|---|---|
| Open | $1.22 | P/E Ratio | -0.54 |
| Prev. Close | $1.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.19 - $1.29 | Volume | 4,004,635 |
| 52-Wk Range | $0.70 - $8.87 | Avg. Daily Vol. | 3,827,151 |
| Current Price | $1.27 | Mkt Cap | $144.4M |
|---|---|---|---|
| Open | $1.22 | P/E Ratio | -0.54 |
| Prev. Close | $1.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.19 - $1.29 | Volume | 4,004,635 |
| 52-Wk Range | $0.70 - $8.87 | Avg. Daily Vol. | 3,827,151 |
The best Bull and Bear pitches based on recency and number of recommendations.
ESPR is all in on bempedoic acid, which reduces LDL-C cholesterol in statin-resistant/intolerant patients (meaning folks who have intolerable side effects from Lipitor). Massive potential given market size. IPO 2013 at $17. Broke $105 in '15, sunk to… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about ESPR.
Recs
pmatthews987
(< 20)
Submitted: 9/23/2021 7:35:58 PM :
Start Price:
$11.82
NASDAQ:ESPR Score:
-92.24
LDL lowering pills
Recs
lfgonza
(< 20)
Submitted: 11/13/2020 2:50:37 PM :
Start Price:
$28.52
NASDAQ:ESPR Score:
-122.77
Technical analysis (Elliot Wave and Fibonachi) supports the upside potential.
Recs
screach
(79.61)
Submitted: 4/4/2020 1:21:14 PM :
Start Price:
$32.05
NASDAQ:ESPR Score:
-172.35
blockbuster drug approval not reflected in stock price. What's not to like?
Find the members with the highest scoring picks in ESPR.
TerryHoodSr (47.98) Score: +648.65
The Score Leader is the player with the highest score across all their picks in ESPR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Hendrickson71 | < 20 | 9/30/2015 |
|
NS | $21.86 | -94.19% | +137.93% | +232.12 | 1 Comment | |
| mangotime | 36.29 | 3/26/2015 |
|
5Y | $85.33 | -98.51% | +121.80% | +220.32 | 0 Comment | |
| joe508mama | 29.70 | 3/17/2015 |
|
5Y | $88.63 | -98.57% | +119.31% | +217.88 | 0 Comment | |
| kevinshaw98 | 35.44 | 3/25/2015 |
|
3W | $94.20 | -98.65% | +118.31% | +216.96 | 0 Comment | |
| GuruGrowth | 47.45 | 3/25/2015 |
|
5Y | $102.74 | -98.76% | +117.44% | +216.21 | 0 Comment | |
| Avi12 | 57.01 |
|
|
3Y | $109.73 | -98.84% | +115.79% | +214.63 | 0 Comment | |
| AntMan56 | 49.43 | 3/23/2015 |
|
5Y | $109.73 | -98.84% | +115.79% | +214.63 | 0 Comment | |
| cclark04 | 43.63 | 3/23/2015 |
|
3M | $109.73 | -98.84% | +115.79% | +214.63 | 0 Comment | |
| WildShaman | 78.39 | 7/9/2018 |
|
5Y | $44.59 | -97.15% | +64.39% | +161.54 | 0 Comment | |
|
MarkBiotech | < 20 | 8/21/2018 |
|
5Y | $49.31 | -97.42% | +58.56% | +155.98 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
